Download PDF
Semin intervent Radiol 2023; 40(04): 327-334
DOI: 10.1055/s-0043-1770713
Review Article

Update on Endovascular Therapy for Fibroids and Adenomyosis

Merve Ozen
1   Department of Radiology, University of Kentucky College of Medicine, Lexington, Kentucky
,
Ronak Patel
2   University of Kentucky College of Medicine, William R. Willard Medical Education Building, Lexington, Kentucky
,
Mark Hoffman
3   Department of Obstetrics and Gynecology, University of Kentucky College of Medicine, Lexington, Kentucky
,
Driss Raissi
1   Department of Radiology, University of Kentucky College of Medicine, Lexington, Kentucky
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Uterine fibroids and adenomyosis are prevalent benign neoplasms that can lead to serious deleterious health effects including life-threatening anemia, prolonged menses, and pelvic pain; however, up to 40% of women remain undiagnosed. Traditional treatment options such as myomectomy or hysterectomy can effectively manage symptoms but may entail longer hospital stays and hinder future fertility. Endovascular treatment, such as uterine artery embolization (UAE), is a minimally invasive procedure that has emerged as a well-validated alternative to surgical options while preserving the uterus and offering shorter hospital stays. Careful patient selection and appropriate techniques are crucial to achieving optimal outcomes. There have been advancements in recent times that encompass pre- and postprocedural care aimed at enhancing results and alleviating discomfort prior to, during, and after UAE. Furthermore, success and reintervention rates may also depend on the size and location of the fibroids. This article reviews the current state of endovascular treatments of uterine fibroids and adenomyosis.

Keywords

fibroid - adenomyosis - embolization - uterine artery embolization - interventional radiology


Publication History

Article published online:
10 August 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Krentel H, De Wilde RL. Prevalence of adenomyosis in women undergoing hysterectomy for abnormal uterine bleeding, pelvic pain or uterine prolapse - a retrospective cohort study. Ann Med Surg (Lond) 2022; 78: 103809-103809
    PubMedGoogle Scholar
  • 2 Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003; 188 (01) 100-107
    CrossrefPubMedGoogle Scholar
  • 3 Stewart EA, Nowak RA. Uterine fibroids: hiding in plain sight. Physiology (Bethesda) 2022; 37 (01) 16-27
    PubMedGoogle Scholar
  • 4 Ramirez-Caban L, Kannan A, Goggins ER, Shockley ME, Haddad LB, Chahine EB. Factors that lengthen patient hospitalizations following laparoscopic hysterectomy. JSLS 2020; 24 (03) e2020.00029
    CrossrefPubMedGoogle Scholar
  • 5 Stovall DW. Alternatives to hysterectomy: focus on global endometrial ablation, uterine fibroid embolization, and magnetic resonance-guided focused ultrasound. Menopause 2011; 18 (04) 437-444
    PubMedGoogle Scholar
  • 6 Kröncke T. An update on uterine artery embolization for uterine leiomyomata and adenomyosis of the uterus. Br J Radiol 2022; 96 (1143): 20220121
    CrossrefPubMedGoogle Scholar
  • 7 Coyne KS, Harrington A, Currie BM, Chen J, Gillard P, Spies JB. Psychometric validation of the 1-month recall uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). J Patient Rep Outcomes 2019; 3 (01) 57-10
    CrossrefPubMedGoogle Scholar
  • 8 Yang L, Navuluri R. Uterine fibroids and adenomyosis: imaging and treatment. Contemporary Diagnostic Radiology 2021; 44 (22) 1-7
    CrossrefPubMedGoogle Scholar
  • 9 Caridi TM. Uterine artery embolization for adenomyosis. Tech Vasc Interv Radiol 2021; 24 (01) 100726-100726
    CrossrefPubMedGoogle Scholar
  • 10 Vaidya S, Dighe M. Uterine fibroid embolization imaging: interventionalist's perspective. Ultrasound Q 2009; 25 (04) 185-194
    CrossrefPubMedGoogle Scholar
  • 11 Çakır Ç, Kılınç F, Deniz MA, Karakaş S. Can pre-procedural MRI signal intensity ratio predict the success of uterine artery embolization in treatment of myomas?. Turk J Med Sci 2021; 51 (03) 1380-1387
    CrossrefPubMedGoogle Scholar
  • 12 Munro MG, Critchley HOD, Broder MS, Fraser IS. FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011; 113 (01) 3-13
    CrossrefPubMedGoogle Scholar
  • 13 Lacayo EA, Richman DL, Acord MR. et al. Leiomyoma infarction after uterine artery embolization: influence of embolic agent and leiomyoma size and location on outcome. J Vasc Interv Radiol 2017; 28 (07) 1003-1010
    CrossrefPubMedGoogle Scholar
  • 14 Koziarz A, Patel NR, Kennedy SA. et al. Uterine artery embolization for pedunculated subserosal fibroids: a systematic review and meta-analysis. J Vasc Interv Radiol 2022; 33 (09) 1025-1031.e3
    CrossrefPubMedGoogle Scholar
  • 15 Kunchala S, Dumoff K, Shafique K, Kinson MS, Shlansky-Goldberg RD. Expulsion of diffuse adenomyosis following uterine artery embolization. J Vasc Interv Radiol 2020; 31 (11) 1908-1911
    CrossrefPubMedGoogle Scholar
  • 16 Sanampudi S, Gabriel G, Hoffman M, Raissi D. Impending fibroid expulsion on MRI after uterine fibroid embolization. Radiol Case Rep 2019; 14 (06) 673-677
    CrossrefPubMedGoogle Scholar
  • 17 Andrews RT, Spies JB, Sacks D. et al; Task Force on Uterine Artery Embolization and the Standards Division of the Society of Interventional Radiology. Patient care and uterine artery embolization for leiomyomata. J Vasc Interv Radiol 2009; 20 (07) S307-S311
    CrossrefPubMedGoogle Scholar
  • 18 Khalsa B, Costantino M, Goodwin S. Uterine artery embolization followed by elective myomectomy for the treatment of intracavitary fibroids: preliminary experience. J Vasc Interv Radiol 2017; 28 (02) S47
    CrossrefPubMedGoogle Scholar
  • 19 Kohi MP, Spies JB. Updates on uterine artery embolization. Semin Intervent Radiol 2018; 35 (01) 048-055
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Management of symptomatic uterine leiomyomas: ACOG Practice Bulletin, Number 228. Obstetrics and Gynecology (New York 1953) 2021; 137 (06) e100-e115
    CrossrefPubMedGoogle Scholar
  • 21 Committee Opinion No. 557: Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstetrics and Gynecology (New York 1953) 2013; 121 (04) 891-896
    CrossrefPubMedGoogle Scholar
  • 22 Horton AW, Patel U, Belli AM. An unusual arterial supply to the uterus. A case report and review of anatomy-implications for uterine artery embolization. Clin Radiol 2010; 65 (12) 1038-1042
    CrossrefPubMedGoogle Scholar
  • 23 Kim HS, Paxton BE. Development of a hypertrophic ovarian artery after uterine artery embolization with polyvinyl alcohol particles. Cardiovasc Intervent Radiol 2007; 30 (05) 1033-1036
    CrossrefPubMedGoogle Scholar
  • 24 Matson M, Nicholson A, Belli AM. Anastomoses of the ovarian and uterine arteries: a potential pitfall and cause of failure of uterine embolization. Cardiovasc Intervent Radiol 2000; 23 (05) 393-396
    CrossrefPubMedGoogle Scholar
  • 25 Wang MQ, Liu FY, Duan F, Wang ZJ, Song P, Song L. Ovarian artery embolization supplementing hypogastric-uterine artery embolization for control of severe postpartum hemorrhage: report of eight cases. J Vasc Interv Radiol 2009; 20 (07) 971-976
    CrossrefPubMedGoogle Scholar
  • 26 Ozen M, Momin S, Myers CB, Hoffman M, Raissi D. Primary bilateral ovarian artery embolization for uterine leiomyomatosis in the setting of a rare anatomic variant - hypoplastic uterine arteries. Radiol Case Rep 2021; 16 (09) 2426-2428
    CrossrefPubMedGoogle Scholar
  • 27 Razavi MK, Wolanske KA, Hwang GL, Sze DY, Kee ST, Dake MD. Angiographic classification of ovarian artery-to-uterine artery anastomoses: initial observations in uterine fibroid embolization. Radiology 2002; 224 (03) 707-712
    CrossrefPubMedGoogle Scholar
  • 28 Ozen M, Birmingham E, Hoffman M, Raissi D. Non-surgical management of abdominal ectopic pregnancy with uterine artery embolization. Radiol Case Rep 2022; 17 (05) 1631-1633
    CrossrefPubMedGoogle Scholar
  • 29 Laughlin-Tommaso S, Barnard EP, AbdElmagied AM. et al. FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery. Am J Obstet Gynecol 2019; 220 (02) 174.e1-174.e13
    CrossrefPubMedGoogle Scholar
  • 30 Himiniuc LMM, Murarasu M, Toma B. et al. Transradial embolization, an underused type of uterine artery embolization approach: a systematic review. Medicina (Kaunas) 2021; 57 (02) 1-10
    PubMedGoogle Scholar
  • 31 Sher A, Garvey A, Kamat S. et al. Single-system experience with outpatient transradial uterine artery embolization: safety, feasibility, outcomes, and early rates of return. AJR Am J Roentgenol 2021; 216 (04) 975-980
    CrossrefPubMedGoogle Scholar
  • 32 Nakhaei M, Mojtahedi A, Faintuch S, Sarwar A, Brook OR. Transradial and transfemoral uterine fibroid embolization comparative study: technical and clinical outcomes. J Vasc Interv Radiol 2020; 31 (01) 123-129
    CrossrefPubMedGoogle Scholar
  • 33 Sofy AA, Tsui S. Comparison of polyvinyl alcohol particles and tris-acryl gelatin microspheres embolic agents used in uterine artery embolization: a systematic review and meta-analysis. Turk J Obstet Gynecol 2023; 20 (01) 74-84
    CrossrefPubMedGoogle Scholar
  • 34 Worthington-Kirsch RL. Uterine artery embolization: state of the art. Semin Intervent Radiol 2004; 21 (01) 37-42
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Szejnfeld D, Santos RFT, Kambara AM. et al. Uterine artery embolization with highly compressible calibrated microspheres for the treatment of uterine fibroids. Radiol Bras 2022; 55 (04) 231-235
    PubMedGoogle Scholar
  • 36 Zhang Y, Xu Y, Zhang X. et al. 8Spheres conformal microspheres as embolic agents for symptomatic uterine leiomyoma therapy in uterine artery embolization (UAE): a prospective clinical trial. Medicine (Baltimore) 2023; 102 (09) e33099
    CrossrefPubMedGoogle Scholar
  • 37 Yuan K, Zhang JL, Yan JY. et al. Uterine artery embolization with small-sized particles for the treatment of symptomatic adenomyosis: a 42-month clinical follow-up. Int J Gen Med 2021; 14: 3575-3581
    CrossrefPubMedGoogle Scholar
  • 38 Spies JB. Recovery after uterine artery embolization: understanding and managing short-term outcomes. J Vasc Interv Radiol 2003; 14 (10) 1219-1222
    PubMedGoogle Scholar
  • 39 Spencer EB, Stratil P, Mizones H. Clinical and periprocedural pain management for uterine artery embolization. Semin Intervent Radiol 2013; 30 (04) 354-363
    Article in Thieme ConnectPubMedGoogle Scholar
  • 40 Tran-Harding KN, Han Q, Ferrell SC, Raissi D. Postprocedure intravenous patient-controlled analgesia compared to epidural patient-controlled analgesia use after uterine fibroid embolization: a clinical audit. Anesth Essays Res 2019; 13 (02) 287-291
    CrossrefPubMedGoogle Scholar
  • 41 Katsumori T, Miura H, Yoshikawa T, Seri S, Kotera Y, Asato A. Intra-arterial lidocaine administration for anesthesia after uterine artery embolization with trisacryl gelatin microspheres for leiomyoma. J Vasc Interv Radiol 2020; 31 (01) 114-120
    CrossrefPubMedGoogle Scholar
  • 42 Yoon J, Valenti D, Muchantef K. et al. Superior hypogastric nerve block as post-uterine artery embolization analgesia: a randomized and double-blind clinical trial. Radiology 2019; 292 (01) 269-269
    CrossrefPubMedGoogle Scholar
  • 43 Pisanie JLD, Commander CW, Burke CT. Management of postprocedural uterine artery embolization pain. Semin Intervent Radiol 2021; 38 (05) 588-594
    Article in Thieme ConnectPubMedGoogle Scholar
  • 44 Leonhardt H, Aziz A, Lönn L. Post-embolization syndrome and complete expulsion of a leiomyoma after uterine artery embolization. Acta Obstet Gynecol Scand 2005; 84 (03) 303-305
    CrossrefPubMedGoogle Scholar
  • 45 Szkodziak P, Pyra K, Szkodziak F. et al. The Lublin protocol of the uterine arteries embolization in the treatment of symptomatic uterine fibroids. J Vis Exp 2020; 2020 (163): 1-44
    PubMedGoogle Scholar
  • 46 Waldron MG, Kassamani YW, O'Mahony AT. et al. Uterine artery embolisation of fibroids and the phenomenon of post-embolisation syndrome: a systematic review. Diagnostics (Basel) 2022; 12 (12) 2916
    CrossrefPubMedGoogle Scholar
  • 47 Duvnjak S, Andersen PE. Intra-arterial lidocaine administration during uterine fibroid embolization to reduce the immediate postoperative pain: a prospective randomized study. CVIR Endovasc 2020; 3 (01) 10-10
    CrossrefPubMedGoogle Scholar
  • 48 Kim SY, Koo BN, Shin CS, Ban M, Han K, Kim MD. The effects of single-dose dexamethasone on inflammatory response and pain after uterine artery embolisation for symptomatic fibroids or adenomyosis: a randomised controlled study. BJOG 2016; 123 (04) 580-587
    CrossrefPubMedGoogle Scholar
  • 49 Ochmanek E, Brown MA, Rochon PJ. Fibroid expulsion after uterine artery embolization. Semin Intervent Radiol 2019; 36 (02) 126-132
    Article in Thieme ConnectPubMedGoogle Scholar
  • 50 Shlansky-Goldberg RD, Coryell L, Stavropoulos SW. et al. Outcomes following fibroid expulsion after uterine artery embolization. J Vasc Interv Radiol 2011; 22 (11) 1586-1593
    CrossrefPubMedGoogle Scholar
  • 51 Gozzo C, Failla G, Musumeci A. et al. Microspheres vaginal discharge as a complication after uterine artery embolization for intramural/submucosal fibroid. Radiol Case Rep 2021; 16 (06) 1591-1595
    CrossrefPubMedGoogle Scholar
  • 52 Dariushnia SR, Nikolic B, Stokes LS, Spies JB. Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. J Vasc Interv Radiol 2014; 25 (11) 1737-1747
    CrossrefPubMedGoogle Scholar
  • 53 Ma J, Brown B, Liang E. Long-term durability of uterine artery embolisation for treatment of symptomatic adenomyosis. Aust N Z J Obstet Gynaecol 2021; 61 (02) 290-296
    CrossrefPubMedGoogle Scholar
  • 54 Caridi TM, De la Garza-Ramos C, Brook OR. et al. Uterine artery embolization for symptomatic adenomyosis: proceedings from a Society of Interventional Radiology Foundation Research Consensus Panel. J Vasc Interv Radiol 2022; 33 (05) 586-592
    CrossrefPubMedGoogle Scholar
  • 55 Kroencke TJ, Scheurig C, Lampmann LEH. et al. Acrylamido polyvinyl alcohol microspheres for uterine artery embolization: 12-month clinical and MR imaging results. J Vasc Interv Radiol 2008; 19 (01) 47-57
    CrossrefPubMedGoogle Scholar
  • 56 Kim MD, Kim YM, Kim HC. et al. Uterine artery embolization for symptomatic adenomyosis: a new technical development of the 1-2-3 protocol and predictive factors of MR imaging affecting outcomes. J Vasc Interv Radiol 2011; 22 (04) 497-502
    CrossrefPubMedGoogle Scholar
  • 57 Luo Y-H, Xi IL, Wang R. et al. Deep learning based on MR imaging for predicting outcome of uterine fibroid embolization. J Vasc Interv Radiol 2020; 31 (06) 1010-1017.e3
    CrossrefPubMedGoogle Scholar
  • 58 Firouznia K, Ghanaati H, Sanaati M, Jalali AH, Shakiba M. Uterine artery embolization in 101 cases of uterine fibroids: do size, location, and number of fibroids affect therapeutic success and complications?. Cardiovasc Intervent Radiol 2008; 31 (03) 521-526
    CrossrefPubMedGoogle Scholar
  • 59 Katsumori T, Yoshikawa T, Miura H. Insufficient leiomyoma infarction in uterine artery embolization: relationship with tumor location. J Vasc Interv Radiol 2019; 30 (05) 668-675.e1
    CrossrefPubMedGoogle Scholar
  • 60 Siskin GP. Optimizing fibroid infarction rates after uterine artery embolization. J Vasc Interv Radiol 2019; 30 (05) 677-678
    CrossrefPubMedGoogle Scholar
  • 61 Llewellyn O, Patel NR, Mallon D, Quinn SD, Hamady M. Uterine artery embolisation for women with giant versus non-giant uterine fibroids: a systematic review and meta-analysis. Cardiovasc Intervent Radiol 2020; 43 (05) 684-693
    CrossrefPubMedGoogle Scholar
  • 62 Leonardo-Pinto JP, Maghsoudlou P, Salazar GM. et al. Diagnosis of gynecologic malignancy after the treatment of presumed benign fibroid disease with interventional radiology procedures: a retrospective cohort study. Fertil Steril 2023; S0015-0282 (23)00171-1
    PubMedGoogle Scholar
  • 63 Mailli L, Patel S, Das R. et al. Uterine artery embolisation: fertility, adenomyosis and size - what is the evidence?. CVIR Endovasc 2023; 6 (01) 8
    CrossrefPubMedGoogle Scholar
  • 64 Akhatova A, Aimagambetova G, Bapayeva G. et al. Reproductive and obstetric outcomes after UAE, HIFU, and TFA of uterine fibroids: systematic review and meta-analysis. Int J Environ Res Public Health 2023; 20 (05) 4480
    CrossrefPubMedGoogle Scholar
  • 65 Zanolli NC, Bishop KC, Kuller JA, Price TM, Harris BS. Fibroids and fertility: a comparison of myomectomy and uterine artery embolization on fertility and reproductive outcomes. Obstet Gynecol Surv 2022; 77 (08) 485-494
    CrossrefPubMedGoogle Scholar
  • 66 Ghanaati H, Avanaki MA, Ghavami N. et al. Pregnancy rate and outcomes following uterine artery embolization for uterine arteriovenous malformations: a systematic review and meta-analysis. J Vasc Interv Radiol 2023; S1051-0443 (23)00227-0
    PubMedGoogle Scholar
  • 67 Jiang L, Han Y, Song Z, Li Y. Pregnancy outcomes after uterus-sparing operative treatment for adenomyosis: a systematic review and meta-analysis. J Minim Invasive Gynecol 2023; S1553-4650 (23)00113-9
    PubMedGoogle Scholar